CA
NZ
UK
AU
IND
US
…
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, lower mid-market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and Med-Tech outsourced services, pharma products, and Med-Tech Products sectors. The firm prefers to invest in companies based in United Kingdom, New York, Germany, Austria, Switzerland, Spain, France and Nordic region. It prefers to make equity investment between 4.77 million pounds ($5.91 million) and 300 million euro ($348.8 million), for small mid cap between 40 million pounds ($49.54 million) and 125 pounds million ($154.82 million) and for small cap between 10 million pounds ($12.39 million) and 25 million pounds ($30.96 million), with enterprise value between 10 million euro ($10.74 million) and 1000 million euro ($1073.62 million). Bridgepoint Group plc was founded in 1985 and is based in London, United Kingdom with additional offices in North America, Asia and Europe. Bridgepoint Group plc formerly known as Bridgepoint Group Limited.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 85.70M | 80.70M | 86.00M | 127.40M | 62.60M |
| Minority interest | -15.20M | -4.30M | 0.00M | - | - |
| Net income | 41.50M | 64.80M | 70.70M | 120.60M | 57.80M |
| Selling general administrative | 2.10M | 2.30M | 1.90M | - | - |
| Gross profit | 411.80M | 261.40M | 199.60M | 208.80M | 164.50M |
| Reconciled depreciation | 67.90M | 36.20M | 17.50M | 18.30M | 15.00M |
| Ebit | 121.90M | 101.80M | 91.30M | 118.80M | 70.30M |
| Ebitda | 186.80M | 138.00M | 110.00M | 150.40M | 83.50M |
| Depreciation and amortization | 64.90M | 36.20M | 18.70M | 31.60M | 13.20M |
| Operating income | 264.50M | 82.10M | 99.90M | 118.80M | 70.30M |
| Other operating expenses | 212.20M | 306.20M | 195.40M | 188.70M | 199.70M |
| Interest expense | 36.20M | 21.10M | 5.30M | 4.70M | 5.90M |
| Tax provision | 29.00M | 11.60M | 15.30M | 6.80M | 4.80M |
| Interest income | 4.40M | 7.80M | 9.70M | 2.90M | 3.00M |
| Net interest income | -88.30M | -13.80M | 4.10M | -4.10M | -8.90M |
| Income tax expense | 29.00M | 11.60M | 15.30M | 6.80M | 4.80M |
| Total revenue | 476.70M | 388.30M | 295.30M | 306.40M | 268.90M |
| Total operating expenses | 147.30M | 179.30M | 99.70M | 91.10M | 95.30M |
| Cost of revenue | 64.90M | 126.90M | 95.70M | 97.60M | 104.40M |
| Total other income expense net | -178.80M | -1.40M | -13.90M | 8.60M | -7.70M |
| Net income from continuing ops | 56.70M | 69.10M | 70.70M | 120.60M | 57.80M |
| Net income applicable to common shares | - | - | - | 120.60M | 57.80M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| Total assets | 5216.60M | 4094.90M | 2377.70M | - | 1787.80M |
| Intangible assets | 711.90M | 230.80M | 11.50M | - | 14.50M |
| Other current assets | 152.20M | 109.10M | 203.60M | - | 766.90M |
| Total liab | 4028.60M | 2903.70M | 1656.50M | - | 1015.10M |
| Total stockholder equity | 995.30M | 983.40M | 721.20M | - | 772.70M |
| Other current liab | -241.10M | 137.40M | 122.10M | - | 127.40M |
| Common stock | 0.10M | 0.10M | 0.10M | - | 0.10M |
| Capital stock | 0.10M | 0.10M | 0.10M | - | 0.10M |
| Retained earnings | 484.20M | 555.10M | 418.70M | - | 473.70M |
| Other liab | - | - | - | - | 651.90M |
| Good will | 519.20M | 559.10M | 105.10M | - | 105.10M |
| Other assets | - | - | 74.60M | - | 61.90M |
| Cash | 334.90M | 90.80M | 238.80M | - | 196.00M |
| Total current liabilities | 12.60M | 408.10M | 337.70M | - | 258.00M |
| Current deferred revenue | - | - | 151.80M | - | - |
| Net debt | 212.90M | 2226.70M | 1038.20M | - | 515.40M |
| Short term debt | 38.10M | 34.10M | 26.80M | - | 8.70M |
| Short long term debt | 25.50M | 20.60M | 14.90M | - | 2.60M |
| Short long term debt total | 547.80M | 2317.50M | 1277.00M | - | 711.40M |
| Other stockholder equity | 445.30M | 375.10M | 289.80M | - | 298.90M |
| Property plant equipment | - | - | - | - | 85.50M |
| Total current assets | 3515.80M | 2303.90M | 1795.50M | - | 1247.80M |
| Net tangible assets | - | - | - | - | 653.10M |
| Short term investments | 2903.30M | 1978.20M | 1356.30M | - | 841.30M |
| Net receivables | 125.40M | 125.80M | 17.50M | - | 12.20M |
| Long term debt | 3119.20M | 2209.00M | 1180.50M | - | 625.60M |
| Inventory | - | -125.80M | -20.70M | - | - |
| Accounts payable | 215.60M | 233.70M | 185.90M | - | 121.90M |
| Accumulated other comprehensive income | 65.70M | 51.10M | 12.60M | - | - |
| Non currrent assets other | 34.60M | 2048.90M | 90.50M | - | 334.90M |
| Non current assets total | 1700.80M | 1791.00M | 582.20M | - | 540.00M |
| Capital lease obligations | 96.60M | 87.90M | 81.60M | - | 83.20M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -589.00M | -928.90M | -320.00M | -57.30M | -185.80M |
| Change to liabilities | - | - | - | 0.00M | -2.10M |
| Total cashflows from investing activities | -616.70M | -928.90M | -320.00M | -57.30M | -163.00M |
| Net borrowings | -1050.50M | 268.20M | -108.60M | -19.40M | -37.20M |
| Total cash from financing activities | 672.60M | 776.10M | 325.60M | -86.60M | 318.60M |
| Net income | 41.50M | 80.70M | 70.70M | 127.40M | 62.60M |
| Change in cash | 175.90M | -155.00M | 94.20M | -106.70M | 170.20M |
| Begin period cash flow | 159.00M | 314.80M | 220.60M | 327.30M | 157.10M |
| End period cash flow | 334.90M | 159.80M | 314.80M | 220.60M | 327.30M |
| Total cash from operating activities | 113.10M | 10.80M | 95.00M | 33.90M | 23.10M |
| Issuance of capital stock | - | - | - | 0.00M | 309.80M |
| Depreciation | 64.90M | 36.20M | 18.70M | 18.30M | 15.00M |
| Other cashflows from investing activities | - | 6.90M | 4.70M | 4.50M | 29.10M |
| Dividends paid | 91.70M | 80.10M | 68.00M | 62.80M | 30.00M |
| Change to account receivables | 10.50M | -6.90M | -5.60M | - | -10.30M |
| Sale purchase of stock | -4.10M | -9.80M | -60.20M | - | 69.50M |
| Other cashflows from financing activities | 1768.00M | 739.50M | 712.30M | -8.50M | 117.60M |
| Change to netincome | - | - | - | -65.50M | -37.30M |
| Capital expenditures | 32.30M | 2.90M | 4.00M | 22.60M | 6.30M |
| Change in working capital | 38.10M | -74.60M | 50.40M | -39.50M | -12.40M |
| Stock based compensation | 64.80M | 38.60M | 4.50M | 0.40M | 2.90M |
| Other non cash items | -31.40M | -70.10M | -58.10M | -72.70M | 15.00M |
| Free cash flow | 80.80M | 7.90M | 91.00M | 11.30M | 16.80M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BPT Bridgepoint Group Plc |
-2.20 0.55% |
396.60 | 47.80 | 9.69 | 3.33 | 2.06 | 4.60 | 11.54 |
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 | - |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 | - |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 | 6.56 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 | - |
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, lower mid-market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and Med-Tech outsourced services, pharma products, and Med-Tech Products sectors. The firm prefers to invest in companies based in United Kingdom, New York, Germany, Austria, Switzerland, Spain, France and Nordic region. It prefers to make equity investment between 4.77 million pounds ($5.91 million) and 300 million euro ($348.8 million), for small mid cap between 40 million pounds ($49.54 million) and 125 pounds million ($154.82 million) and for small cap between 10 million pounds ($12.39 million) and 25 million pounds ($30.96 million), with enterprise value between 10 million euro ($10.74 million) and 1000 million euro ($1073.62 million). Bridgepoint Group plc was founded in 1985 and is based in London, United Kingdom with additional offices in North America, Asia and Europe. Bridgepoint Group plc formerly known as Bridgepoint Group Limited.
| Name | Title | Year Born |
|---|---|---|
| Mr. William N. Jackson | Exec. Chairman | 1964 |
| Mr. Adam M. Jones | COO, CFO & Director | NA |
| Mr. Ben Bainbridge | Chief of Staff | NA |
| Mr. Jonathan Raoul Hughes | Chief Executive | 1965 |
| Mr. William Nicholas Jackson | Founder | 1963 |
| Ms. Ruth Catherine Prior | Group CFO, Partner & Director | 1967 |
| Mr. Peter Labbat | Group Managing Partner, Co-Head of Business Development & Vice chair of ECP | 1966 |
| Mr. Douglas W. Kimmelman | ECP Executive Chairman & ECP Founder | 1960 |
| Mr. Jamie Lucas | Chief Operating Officer of Credit | NA |
| Mr. Murray D. Karp CPA | ECP Managing Partner & ECP COO | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...